- Home
- ASRT vs ANVS Comparison
ASRT vs ANVS Comparison
Compare ASRT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | ANVS |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 111.3M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ASRT | ANVS |
|---|---|---|
| Price | $0.66 | $3.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $13.50 |
| AVG Volume (30 Days) | 307.1K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $137,354,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.22 | N/A |
| 52 Week Low | $0.51 | $1.11 |
| 52 Week High | $1.01 | $5.60 |
Technical Indicators
Market Signals| Indicator | ASRT | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 32.28 | 47.48 |
| Support Level | $0.70 | $3.46 |
| Resistance Level | $0.75 | $4.04 |
| Average True Range (ATR) | 0.04 | 0.37 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 13.68 | 10.29 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.